Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of quinoline-based derivatives as c-Met inhibitors for the treatment of non-small cell lung cancer. | Eur J Med Chem | 2026 | 42748863 | PubTator, text mining | PubMed |
| Pharmaceutical Potential of Antibody-Drug Conjugate Doublets for Targeted Treatment of Cancers Heterogeneously Expressing RON Receptor Tyrosine Kinase. | Curr Cancer Drug Targets | 2026 | 42693721 | PubTator, text mining | PubMed |
| RON receptor tyrosine kinase regulates abiraterone resistance in prostate cancer via the methylation-dependent and independent dual functions of DNMT1. | Oncogene | 2026 | 42498731 | PubTator, text mining | PubMed |
| Genome-wide pleiotropic analysis identifies shared genetic architecture within the cognition-immune nexus. | Transl Psychiatry | 2026 | 42386713 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in colorectal cancer: molecular design, preclinical advances, and translational challenges. | Cancer Chemother Pharmacol | 2026 | 42207299 | PubTator, text mining | PubMed |
| Relation of Osteopontin Expression to Tumor-Associated Macrophages-Derived Transforming Growth Factor Beta 1 Expression in Non-small Cell Lung Carcinoma. | J Microsc Ultrastruct | 2026 | 42040212 | PubTator, text mining | PubMed |
| Investigation of molecular immune regulation mechanisms and therapeutic target prediction in pancreatic cancer based on bioinformatics and genetics. | Clinics (Sao Paulo) | 2026 | 42001564 | PubTator, text mining | PubMed |
| Expression and Clinical Significance of Pim-1 and RON in Lung Cancer Patients with Benign and Malignant Pleural Effusion. | Clin Lab | 2026 | 41979639 | PubTator, text mining | PubMed |
| Osteosarcoma cells promote intracellular iron detoxification to mitigate GPX4-mediated ferroptosis. | Cancer Gene Ther | 2026 | 41872463 | PubTator, text mining | PubMed |
| Genomic landscape of pleural mesothelioma in Japanese patients: A comprehensive analysis using nationwide database. | Transl Oncol | 2026 | 41855858 | PubTator, text mining | PubMed |
| Defining the Active Conformation of Typical Protein Kinase Domains from Substrate-Bound PDB Structures Enables Active-State AlphaFold2 Models for All 437 Human Catalytic Protein Kinases. | bioRxiv | 2026 | 41757035 | PubTator, text mining | PubMed |
| Tetralogy of Fallot: Genetic, Epigenetic and Clinical Insights into a Multifactorial Congenital Heart Disease. | Genes (Basel) | 2026 | 41751564 | PubTator, text mining | PubMed |
| From Latent Manifolds to Targeted Molecular Probes: An Interpretable, Kinome-Scale Generative Machine Learning Framework for Family-Based Kinase Ligand Design. | Biomolecules | 2026 | 41750280 | PubTator, text mining | PubMed |
| The EEG-Indexed Impacts of Caffeine on Auditory Novelty Processing Across Phases of the Human Menstrual Cycle. | Eur J Neurosci | 2026 | 41740974 | PubTator, text mining | PubMed |
| An integrative genomic framework to identify remote ischemic preconditioning-responsive genes associated with stroke risk. | Exp Neurol | 2026 | 41690496 | PubTator, text mining | PubMed |
| Clinical characteristics of pulmonary non-tuberculous mycobacterial disease with CFTR variants in the Japanese population. | BMJ Open Respir Res | 2026 | 41638757 | PubTator, text mining | PubMed |
| Genomic Characterization of Oncocytic Carcinoma of the Thyroid Using a Large Multi-Institutional Database. | Otolaryngol Head Neck Surg | 2026 | 41582704 | PubTator, text mining | PubMed |
| Long Noncoding RNA DGUOK-AS1 Promotes Bladder Cancer Progression by Enhancing EFTUD2 Stability. | Cancer Res Treat | 2026 | 40968608 | PubTator, text mining | PubMed |
| Towards precision medicine for systemic lupus erythematosus and neuropsychiatric manifestations. | Expert Rev Precis Med Drug Dev | 2025 | 42281945 | PubTator, text mining | PubMed |
| When two signals are better than one: Synergistic control of erythropoiesis. | PLoS Biol | 2025 | 41385472 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers